NEW YORK, Sept. 9-Gentris, a North Carolina diagnostics company, will work with Promega to develop clinical pharmacogenomic products, the two companies said today.
The two companies will integrate their technologies into a robotic liquid handling platform designed to provide clinical guidance for physicians in drug prescription and dosing.
Promega, which specializes in biological reagents, will supply its Readit SNP-scoring system. Gentris, which offers pharmacogenomic tests for clinical trials and viral genotyping tests, is now working to develop genotyping kits for drug development.
The companies did not disclose financial details of the agreement.